Regeneron Recalls Libtayo Injection Due to Sterility Concerns

Regeneron Pharmaceuticals is recalling specific lots of Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL, single-dose vials for intravenous infusion. The recall is due to a lack of assurance of sterility. Consumers are advised to stop using the recalled product and contact their healthcare provider or Regeneron for guidance and replacement.